Dragon Pharma Ipamorelin
For athletes, bodybuilders, and fitness enthusiasts seeking to optimize recovery, enhance lean muscle preservation, and improve sleep quality without unwanted side effects, Ipamorelin represents a significant advancement in growth hormone peptide research. As a third-generation growth hormone releasing peptide (GHRP), Ipamorelin offers potent GH stimulation with a remarkably clean side effect profile. This Dragon Pharma Ipamorelin 5mg offering delivers high-purity lyophilized powder in a sterile 2mL vial, providing researchers with a premium compound for investigating GH secretion pathways, anabolic mechanisms, and recovery optimization.
Ipamorelin functions by selectively binding to the ghrelin receptor (GHS-R1a) in the hypothalamus and pituitary, triggering a dose-dependent release of endogenous growth hormone. What sets Ipamorelin apart from other GHRPs is its exceptional selectivity. Research published in the NIH PubMed database demonstrates that Ipamorelin stimulates GH release with high potency while showing minimal effect on cortisol, prolactin, and acetylcholine—hormones that can be elevated by other GHRPs. This selectivity makes Ipamorelin an ideal candidate for research protocols requiring clean GH elevation without unwanted hormonal fluctuations.
The relevance of Ipamorelin to athletic performance is profound. Growth hormone plays a critical role in protein synthesis, collagen formation, lipolysis, and immune function. For athletes engaged in intense training cycles, enhanced GH secretion supports faster recovery from workouts, improved sleep architecture, better preservation of lean muscle mass during caloric deficits, and accelerated repair of connective tissue. Ipamorelin's ability to increase IGF-1 levels further amplifies its anabolic potential, supporting long-term tissue adaptation, joint health, and strength gains. Unlike some GHRPs that can cause significant hunger spikes, Ipamorelin's effects on appetite are mild, making it suitable for research protocols where precise caloric control is desired.
Quality assurance is paramount in peptide research. Each batch of our Ipamorelin 5 mg inventory undergoes rigorous third-party HPLC-MS testing to verify purity and dosage. The most recent batch (November 2023) tested at an exceptional 5.60 mg—exceeding the label claim—with batch number #HDIPM923. This level of transparency and quality control ensures that researchers can trust the integrity of the compounds they are investigating.
For bodybuilders and strength athletes navigating the demands of off-season growth or post-cycle recovery, Ipamorelin offers a versatile tool with a favorable safety profile. Its clean mechanism of action allows researchers to study GH-mediated anabolic effects without the confounding variables of cortisol or prolactin elevation. Whether investigating strategies for enhanced recovery, improved sleep quality, or lean muscle preservation, Dragon Pharma's Ipamorelin delivers the purity, potency, and reliability required for serious research into growth hormone modulation and its effects on athletic performance.
Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.
Usage Guidelines
Ipamorelin is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water or sterile saline prior to research use. For optimal stability, gently swirl the vial after adding the diluent—do not shake vigorously. Standard research protocols often involve reconstituting the 5mg peptide with 2mL of bacteriostatic water, yielding a concentration of 2.5mg/mL. Investigators should then utilize a sterile insulin syringe for precise dosage administration. Typical research dosing ranges from 200-500mcg per administration, often administered 1-2 times daily. Due to its clean side effect profile, Ipamorelin is often preferred for protocols requiring long-term GH stimulation. It is recommended to store the reconstituted peptide in a refrigerator (2-8°C) and use within 30 days to maintain peptide integrity. For optimal GH pulsatility, administer Ipamorelin on an empty stomach, waiting at least 2 hours after meals and 30 minutes before eating.
For researchers investigating comprehensive growth hormone modulation protocols, combining Ipamorelin with complementary peptides can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:
- CJC 1295 No DAC/Ipamorelin: A pre-blended combination of Ipamorelin with a GHRH analog for enhanced GH pulsatility research.
- MK 677: An oral growth hormone secretagogue for comparative research on sustained vs. pulsatile GH elevation.
- Tesamorelin: A GHRH analog for comparative research on GH stimulation mechanisms.